Heart Failure in the Child and Young Adult

Name: Heart Failure in the Child and Young Adult
Price: 230 USD
Availability: InStock
ISBN: 9780443132797

From Bench to Bedside

by Joseph Rossano, John Lynn Jefferies, Anthony C. Chang, Jeffrey A. Towbin, Robert E Shaddy, Shelley Miyamoto

2nd Edition

Publisher: Academic Press

(0 reviews)

Compare Prices

VitalSourceLifetime Access$230.00 AmazonPaperback$155.80 Best PriceeTextShelfPDF$38.00

Book Details

Print ISBN	9780443132797
eText ISBN	9780443132780
Publisher	Academic Press
Publishing Year	2025
Edition	2nd Edition
Language	English
Pages	1030

Heart Failure in the Child and Young Adult, 2nd Edition, published by Academic Press, is a clinical reference that addresses heart failure recognition and management in pediatric patients. Built for pediatric cardiologists, adult cardiologists, intensive care physicians, cardiac surgeons, and basic science researchers in pediatrics and cardiology, the text combines research from multiple contributors with established clinical guidelines.

The volume follows a logical structural progression that connects basic science mechanisms to clinical practice. It transitions from foundational physiological research to diagnostic strategies, therapeutic management, surgical interventions, and emerging topics such as cardiovascular genetics, patient self-management strategies, and nanomedicine.

This updated volume incorporates findings from recent randomized controlled trials in pediatric heart failure to assist clinicians and investigators. The reference supports advanced professional study and clinical decision-making across pediatric intensive care, cardiac surgery, and cardiovascular research environments.

Chapter 1: From molecular and cellular mechanisms to models of heart failure
Chapter 2: Cardiovascular receptors and signaling in heart failure
Chapter 3: Heart failure in the child and young adult: From bench to bedside: Inflammatory mediators in heart failure
Chapter 4: Transcriptional regulation, epigenetic regulation, and transcriptomics of pediatric heart failure
Chapter 5: Mechanisms of hypertrophy in heart failure
Chapter 6: Hemodynamic adaptive mechanisms in heart failure
Chapter 7: Neurohormonal axis and natriuretic peptides in heart failure
Chapter 8: Novel biomarkers in heart failure
Chapter 9: Systolic and diastolic function
Chapter 10: Echocardiographic quantitation of ventricular function
Chapter 11: MRI assessment of heart failure
Chapter 12: Assessment of heart failure by invasive methods
Chapter 13: The lymphatic system in heart failure
Chapter 14: Endothelial dysfunction in heart failure in the child and young adult
Chapter 15: Epidemiology and economics of pediatric heart failure
Chapter 16: Clinical recognition of heart failure in children
Chapter 17: Classification of pediatric heart failure
Chapter 18: Right ventricular dysfunction
Chapter 19: Pediatric myocarditis
Chapter 20: Dilated cardiomyopathy
Chapter 21: Clinical features of restrictive cardiomyopathy and constrictive pericarditis
Chapter 22: Hypertrophic cardiomyopathy
Chapter 23: Left ventricular noncompaction cardiomyopathy
Chapter 24: Arrhythmogenic cardiomyopathies
Chapter 25: Valvular insufficiency and heart failure
Chapter 26: Valvular stenosis and heart failure
Chapter 27: Coronary artery disease in children and young adults
Chapter 28: Chronic heart failure in congenital heart disease including single ventricle circulation
Chapter 29: Heart failure in adults with congenital heart disease
Chapter 30: Dysrhythmias and ventricular dysfunction and heart failure
Chapter 31: Fetal heart failure
Chapter 32: Heart failure in the neonate
Chapter 33: Heart failure in pediatric pulmonary diseases
Chapter 34: Pediatric cardiorenal syndrome
Chapter 35: Heart failure in pediatric oncologic disease
Chapter 36: Neuromuscular disorders
Chapter 37: Sickle cell disease
Chapter 38: The cardiovascular system in systemic inflammatory syndromes
Chapter 39: Outpatient management of pediatric heart failure
Chapter 40: Cardiac intensive care and inpatient management of heart failure
Chapter 41: Quality of life, neurodevelopmental and psychosocial outcomes in pediatric heart failure
Chapter 42: Palliative care
Chapter 43: Quality metrics and quality improvement in pediatric heart failure
Chapter 44: Nursing aspects of heart failure
Chapter 45: Diuretic and invasive fluid management strategies
Chapter 46: Inotropic agents in heart failure
Chapter 47: Phosphodiesterase inhibitors
Chapter 48: Use of vasodilators in heart failure
Chapter 49: Recognition and treatment of low cardiac output states in pediatric cardiac intensive care
Chapter 50: New therapeutic strategies for heart failure
Chapter 51: Electrophysiologic devices in heart failure
Chapter 52: Catheter device therapies for heart failure
Chapter 53: Posttransplant heart failure
Chapter 54: Surgical strategies for the failing single ventricle
Chapter 55: Valve interventions for heart failure
Chapter 56: Principles of mechanical cardiopulmonary support
Chapter 57: Future of mechanical circulatory support devices in children and young adults
Chapter 58: Short-term mechanical cardiopulmo-nary support devices
Chapter 59: Decision-making in ventricular assist device support in pediatric advanced heart failure patients
Chapter 60: Long-term ventricular assist devices in children
Chapter 61: Genetics and genomics
Chapter 62: Genetic testing
Chapter 63: Big data and artificial intelligence in pediatric heart failure
Chapter 64: Outpatient monitoring and self- care
Chapter 65: Cardiac regenerative medicine for congenital heart defects
Chapter 66: Development of digital twin models for heart failure patient treatment
Chapter 67: Nutritional assessment and management in pediatric heart failure
Chapter 68: The role of wearable technology in improving the care of pediatric heart failure